T1D Fund portfolio company i2O Therapeutics is developing several products leveraging GLP-1s, initially for T2D, including a refillable, implantable GLP-1 device that delivers 6 months worth of the hormone, an oral form of long acting GLP-1, as well as a combined oral GLP-1 with Amylin (another important gut hormone)
Ozempic is facing a worldwide shortage owing to high demand thats outpacing Novo Nordisks manufacturing capabilities
12, 25 Mar
Our online doctors can help you weigh all factors, review your health history, discuss potential side effects, and recommend the right medication for your lifestyle and needs
Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method
Power outages and emergency storage situations Power outages present a real storage challenge, especially during summer storms when they can last days